Citius Pharmaceuticals, Inc.
CTXR
$0.58
-$0.02-3.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.86M | -21.23M | -8.22M | -7.96M | -8.79M |
| Total Depreciation and Amortization | 41.50K | -549.30K | 573.40K | 62.00K | 41.40K |
| Total Amortization of Deferred Charges | 1.90M | 2.29M | -- | -- | -- |
| Total Other Non-Cash Items | 646.90K | -3.31M | 3.53M | 2.40M | 2.57M |
| Change in Net Operating Assets | -2.40M | 21.49M | -8.89M | -6.38M | 772.00K |
| Cash from Operations | -8.68M | -1.30M | -13.01M | -11.88M | -5.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | -600.00K | -4.40M | -5.75M | -- |
| Cash from Investing | -2.00M | -600.00K | -4.40M | -5.75M | -- |
| Total Debt Issued | 9.64M | -- | -- | 0.00 | 1.30M |
| Total Debt Repaid | 0.00 | -1.00M | -- | 0.00 | -300.00K |
| Issuance of Common Stock | 14.18M | -- | 20.88M | 15.79M | 10.47M |
| Repurchase of Common Stock | -- | -61.90K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 100.00 | 100.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -100.00 | -100.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -723.30K | -169.30K | -- | -- | -- |
| Cash from Financing | 23.09M | -1.23M | 20.88M | 15.79M | 11.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.42M | -3.13M | 3.47M | -1.84M | 6.06M |